Medgenics / Baxter Biopump Ready for Clinical Trials

October 10, 2011

Medgenics Ltd. confirmed they are currently in talks with Baxter Healthcare Corporation to renew their agreement which expired last September 30, 2011. The said agreement was collaboration for the development of a Factor VIII Biopump for the treatment of hemophilia.

The technology uses the patient’s own tissue from the skin which will produce and deliver therapeutic proteins inside the body through a simple implant. It is also believed that the Biopump, when successfully developed, can treat other chronic diseases such as anemia and hepatitis C, besides hemophilia.

Baxter has not released any comments on the matter but Medgenics confidently reported that the Biopump is ready for clinical trials and is currently in discussion for the earlier company to extend their collaboration which was originally signed two years ago, now with a total investment of US$ 7million.

AIV provides replacement parts for most Baxter IV pumps. Visit the link to view a full listing of available parts and repair services: -pumps.html

About the Author

Laura Collier

Laura Collier

Laura Collier has a Bachelor’s Degree in Communications and a Master’s Degree in Business Administration from the University of North Florida. She is the Marketing Manager at AIV, Inc.

AIV Catalog

Request Your Printed or Electronic Copy Today!
We Respect Your Privacy

Be Part of Our
Biomed Community

Healthcare technology management professionals are a vital link in hospital operations, and we proudly support the national, state, and local associations with ongoing support and resources.

Get Biomed Resources

Why buy from AIV

AIV strives to provide you cost effective options to service equipment. We offer flexible solutions to best suit your needs.